Dallah Healthcare CoSAU:4004 -0.65%92 Dividend Payout Ratio is 0.60 as of Mar. 2026, which is 22% above its 10-year median of 0.49. GuruFocus rates SAU:4004 with a GF Score™ of 92/100 and a GF Value™ of ﷼207.01 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 248 Healthcare Providers & Services companies, Dallah Healthcare Co ranks worse than 54.84% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Dallah Healthcare Co's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.60.
The historical rank and industry rank for Dallah Healthcare Co's Dividend Payout Ratio or its related term are showing as below:
SAU:4004'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.27 Med: 0.49 Max: 1.66
Current: 0.45
During the past 13 years, the highest Dividend Payout Ratio of Dallah Healthcare Co was 1.66. The lowest was 0.27. And the median was 0.49.
SAU:4004's Dividend Payout Ratio is ranked worse than 54.84% of 248
companies
in the Healthcare Providers & Services industry
Industry Median: 0.41
vs SAU:4004: 0.45
During the past 13 years, the highest Trailing Annual Dividend Yield of Dallah Healthcare Co was 9.49%. The lowest was 0.80%. And the median was 1.66%.
During the past 5 years, the average Dividends Per Share Growth Rate was 9.50% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 7.90% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Dallah Healthcare Co was 71.00% per year. The lowest was -28.40% per year. And the median was 6.15% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Dallah Healthcare Co (SAU:4004) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Dallah Healthcare Co Dividend Payout Ratio Related Terms
Dallah Healthcare Co Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Dallah Healthcare Co's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:4004 vs HCA, THC, DVA: Dividend Payout Ratio Comparison
For the Medical Care Facilities subindustry, Dallah Healthcare Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dallah Healthcare Co Dividend Payout Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dallah Healthcare Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Dallah Healthcare Co's Dividend Payout Ratio falls into.
Dallah Healthcare Co Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Dallah Healthcare Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dallah Healthcare Co (SAU:4004) has a Dividend Payout Ratio of 0.60 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Dallah Healthcare Co and its competitors. This is 22% above median its historical median of 0.49. Over the past decade, Dallah Healthcare Co's Dividend Payout Ratio has ranged from 0.27 to 1.66. According to the industry distribution chart, Dallah Healthcare Co ranks #136 out of 248 companies in the Healthcare Providers & Services industry, placing it in the top 54.8%.
Is Dallah Healthcare Co's Dividend Payout Ratio too high?
Dallah Healthcare Co's current Dividend Payout Ratio of 0.60 is 22% above median its 10-year median of 0.49. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 1.66. The Healthcare Providers & Services industry median Dividend Payout Ratio is 0.41. Dallah Healthcare Co's value of 0.60 is 46.3% above this industry median. Based on the distribution chart, Dallah Healthcare Co ranks #136 out of 248 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Dallah Healthcare Co has a GF Score™ of 92/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dallah Healthcare Co's Dividend Payout Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dallah Healthcare Co ranks #136 out of 248 companies for Dividend Payout Ratio. This places Dallah Healthcare Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.41. Dallah Healthcare Co's value of 0.60 is 46.3% above this benchmark. Historically, Dallah Healthcare Co's own Dividend Payout Ratio has ranged from 0.27 to 1.66 over the past decade. While the company's 10-year median is 0.49 vs. the industry median of 0.41, Dallah Healthcare Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Healthcare Providers & Services company?
The median Dividend Payout Ratio among Healthcare Providers & Services companies is 0.41, based on 248 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dallah Healthcare Co's current Dividend Payout Ratio of 0.60 is 46.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Dallah Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median Dividend Payout Ratio is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dallah Healthcare Co's current Dividend Payout Ratio is 0.60, which is 22% above median its own 10-year median of 0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dallah Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Dallah Healthcare Co (SAU:4004) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼207.01, compared to a current price of ﷼107.30 — trading 48.2% below its estimated fair value. The current Dividend Payout Ratio is 0.60, which is 22% above median its 10-year median of 0.49 and 46.3% above the Healthcare Providers & Services industry median of 0.41. Dallah Healthcare Co's overall GF Score™ is 92/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Dallah Healthcare Co (SAU:4004), the current Dividend Payout Ratio is 0.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dallah Healthcare Co (SAU:4004) Overvalued in 2026?
Based on GuruFocus' analysis, Dallah Healthcare Co stock appears to be undervalued.
The current stock price of ﷼107.30 is trading 48.2% below its estimated GF Value™ of ﷼207.01.
GuruFocus considers Dallah Healthcare Co to be Possible Value Trap.
Key valuation signals for SAU:4004:
Dividend Payout Ratio: 0.60 (22% above median its 10-year median of 0.49)
GF Value™: ﷼207.01 vs. price of ﷼107.30 (48.2% below fair value)
Industry Position: 46.3% above the Healthcare Providers & Services median (#136 of 248)
No single metric tells the full story. See the SAU:4004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
92GF Score
Get the complete analysis for SAU:4004
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4004 has been successfully added to your 
